We are live on ! Find out more

2,709 hedge funds and large institutions have $155B invested in Merck in 2020 Q4 according to their latest regulatory filings, with 302 funds opening new positions, 1,216 increasing their positions, 901 reducing their positions, and 114 closing their positions.

New
Increased
Maintained
Reduced
Closed

165% more first-time investments, than exits

New positions opened: 302 | Existing positions closed: 114

35% more repeat investments, than reductions

Existing positions increased: 1,216 | Existing positions reduced: 901

14% more call options, than puts

Call options by funds: $1.51B | Put options by funds: $1.32B

6% more funds holding

Funds holding: 2,5592,709 (+150)

0.4% less ownership

Funds ownership: 78.22%77.82% (-0.4%)

1% less capital invested

Capital invested by funds: $156B → $155B (-$1.22B)

33% less funds holding in top 10

Funds holding in top 10: 166111 (-55)

Holders
2,709
Holders Change
+150
Holders Change %
+5.86%
% of All Funds
47.93%
Holding in Top 10
111
Holding in Top 10 Change
-55
Holding in Top 10 Change %
-33.13%
% of All Funds
1.96%
New
302
Increased
1,216
Reduced
901
Closed
114
Calls
$1.51B
Puts
$1.32B
Net Calls
+$190M
Net Calls Change
-$202M
Name Holding Trade Value Shares
Change
Change in
Stake
SW
276
SVB Wealth
Massachusetts
$39.2M -$788K -10,308 -2%
Northwestern Mutual Wealth Management
277
Northwestern Mutual Wealth Management
Wisconsin
$39.1M +$944K +12,346 +3%
QP
278
Quilter Plc
United Kingdom
$38.4M +$1.16M +15,160 +3%
EAM
279
Eagle Asset Management
Florida
$38.3M -$105M -1,377,703 -74%
RCAMU
280
Rothschild & Co Asset Management US
Connecticut
$38.2M -$3.5M -45,782 -9%
CFB
281
Cullen/Frost Bankers
Texas
$38.2M -$1.91M -24,967 -5%
CCM
282
Cullen Capital Management
New York
$38.1M -$7.19M -93,947 -16%
DLA
283
Douglas Lane & Associates
New York
$37.9M -$85.9K -1,123 -0.2%
MWNA
284
Marshall Wace North America
New York
$37.7M -$69.3M -906,094 -65%
X
285
Xponance
Pennsylvania
$37.7M +$229K +2,991 +0.6%
JAM
286
Jupiter Asset Management
United Kingdom
$37.3M +$21.9M +286,046 +149%
FT
287
Fiduciary Trust
Massachusetts
$37.3M -$205K -2,682 -0.6%
State of Tennessee, Department of Treasury
288
State of Tennessee, Department of Treasury
Tennessee
$37.1M -$8.77M -114,625 -19%
RA
289
Rovida Advisors
Florida
$36.9M
MLICM
290
Metropolitan Life Insurance Company (MetLife)
New York
$36.8M -$1.45M -18,987 -4%
TPSF
291
Texas Permanent School Fund
Texas
$36.5M -$2.36M -30,838 -6%
Creative Planning
292
Creative Planning
Kansas
$36.4M +$1.58M +20,610 +5%
Cambridge Investment Research Advisors
293
Cambridge Investment Research Advisors
Iowa
$35.9M +$1.21M +15,796 +4%
MA
294
MUFG Americas
New York
$35.9M +$331K +4,334 +1%
GKIM
295
GW&K Investment Management
Massachusetts
$35.8M -$242K -3,158 -0.7%
ZIC
296
ZWJ Investment Counsel
Georgia
$35.6M +$971K +12,699 +3%
VPI
297
Value Partners Investments
Manitoba, Canada
$35.6M +$34.8M +455,467 New
WF
298
Welch & Forbes
Massachusetts
$35.3M -$603K -7,881 -2%
BCIM
299
British Columbia Investment Management
British Columbia, Canada
$35M -$836K -10,927 -2%
AIMCA
300
Alberta Investment Management Corp (AIMCo)
Alberta, Canada
$34.9M +$19.9M +260,219 +139%

MRK Hedge Fund Activity: Q4 2020 in Review

2,709 of the 5,652 institutional investors tracked by Wall St. Rank reported a position in Merck (MRK) for Q4 2020, worth a combined $155B — down 0.78% from $156B a quarter earlier.

Buyers outnumbered sellers: 302 funds opened new MRK positions and 114 closed out — a net gain of 188 holders — while 1,216 added to existing stakes and 901 trimmed.

The largest buyer was Berkshire Hathaway, adding an estimated $505M. The largest seller was Capital World Investors, cutting an estimated $444M.

  • 2,709 institutional investors held Merck (MRK) as of Q4 2020, up from 2,559 in Q3 2020.
  • Funds reported $155B of Merck stock for Q4 2020, down 0.78% quarter-over-quarter.
  • 302 funds opened new Merck positions in Q4 2020 and 114 closed out, a net change of +188 holders.
  • The largest Merck buyer in Q4 2020 was Berkshire Hathaway, an estimated $505M added.
  • The largest Merck seller in Q4 2020 was Capital World Investors, an estimated $444M sold.

Based on aggregated 13F filings for Q4 2020.